India is drafting a new law to enhance drug, cosmetic, and medical device safety standards in response to global concerns raised by the WHO and other health regulators.
- The proposed legislation by the Centre aims to reinforce the role of the Drugs Controller General of India and the Central Drugs Standard Control Organisation in ensuring product quality and safety.
- Increasing global scrutiny, particularly from The WHO, has highlighted quality lapses in Indian drug manufacturing, prompting the need for stricter compliance and market surveillance.
- The law will also address the regulation of cosmetics and medical devices, enhancing the safety protocols to meet international standards and consumer confidence.
Why It Matters
This legislative effort is crucial for restoring trust in Indian medical products globally, ensuring that the country complies with international safety standards, which could significantly impact trade and public health.